Search results :

Regorafenib

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2
Anaemia Anaemia 79% 66% x x
Aspartate aminotransferase increased Aspartate aminotransferase increased 65% 46% x
Hypocalcaemia Hypocalcaemia 59% 18% x x
Hypophosphataemia Hypophosphataemia 57% 11% x
Lymphopenia Lymphopenia 54% 34% x
Malnutrition Malnutrition 47% 28% x x
Decreased appetite Decreased appetite 47% 28% x x
Proteinuria Proteinuria 33% - 60% 30% - 34% x x
Protein urine present Proteinuria 33% - 60% 30% - 34% x x
Hyperbilirubinaemia Hyperbilirubinaemia 45% 17% x x
Alanine aminotransferase increased Alanine aminotransferase increased 45% 30% x
Thrombocytopenia Thrombocytopenia 41% 17% x x
Mediastinal disorder Mediastinal disorder 30% - 39% 6% - 9% x x
Dysphonia Dysphonia 30% - 39% 6% - 9% x x
Urethral disorder Urinary tract disorder 33% 30% x x
Urinary tract disorder Urinary tract disorder 33% 30% x x
Infection Infection 31% - 32% 5% - 17% x x
Infestation Infestation NOS 31% - 32% 5% - 17% x x
Lipase increased Lipase increased 14% - 46% 5% - 19% x
Hyponatraemia Hyponatraemia 30% 22% x x
Hypokalaemia Hypokalaemia 26% 8% x x
Amylase increased Amylase increased 26% 17% x
International normalised ratio increased International normalised ratio increased 24% 17% x
Weight decreased Weight decreased 14% - 32% 8% - 10% x x
Connective tissue disorder Connective tissue disorder 14% 3% x x
Musculoskeletal stiffness Musculoskeletal stiffness 14% 3% x x
Headache Headache 10% - 16% 7% - 9% x x
Nervous system disorder Nervous system disorder 10% - 16% 7% - 9% x x
Neutropenia Neutropenia 3% 0% x
Abdominal pain Abdominal pain x
Gastrointestinal pain Abdominal pain x
Alopecia Alopecia x x
Asthenia Asthenia x x
Fatigue x x
Squamous cell carcinoma Squamous cell carcinoma x
Cyst Cyst x
Diarrhoea Diarrhoea x x
Endocrine disorder Endocrine disorder x
Toxic epidermal necrolysis Toxic epidermal necrolysis x
Erythema multiforme Erythema multiforme x
Stevens-Johnson syndrome x
Dermatitis Rash x x
Rash Rash x x
Fatigue Fatigue x x
Body temperature increased Body temperature increased x x
Fistula Fistula x
Gastroenteritis Gastroenteritis x
Gastrooesophageal reflux disease Gastrooesophageal reflux disease x
Gastrointestinal disorder Gastrointestinal disorder x x
Cardiac disorder Cardiac disorder x
Haemorrhage Haemorrhage x x
Haemoglobin Haemorrhage x x
Hypertension Hypertension x x
Hypertensive crisis Hypertensive crisis x
Hypothyroidism Hypothyroidism x x
Infarction Infarction x
Keratoacanthoma Keratoacanthoma x
Leukopenia Leukopenia x
Myocardial infarction Myocardial infarction x
Acute coronary syndrome Myocardial infarction x
Nail disorder Nail disorder x
Nausea Nausea x
Neoplasm Neoplasm x
Pain Pain x x
Polyp Polyp x
Stevens-Johnson syndrome Stevens-Johnson syndrome x
Stomatitis Stomatitis x
Tremor Tremor x
Angiopathy Angiopathy x x
Vomiting Vomiting x
Dry mouth Dry mouth x
Gastrointestinal perforation Gastrointestinal perforation x x
Hypomagnesaemia Hypomagnesaemia x
Myocardial ischaemia Myocardial ischaemia x x
Dry skin Dry skin x
Liver injury Liver injury x
Traumatic liver injury Liver injury x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x
Hepatotoxicity Hepatotoxicity x
Hepatobiliary disease Hepatobiliary disease x x
Mucosal inflammation Mucosal inflammation x x
Gastrointestinal fistula Gastrointestinal fistula x
Blood uric acid increased Hyperuricaemia x
Hyperuricaemia Hyperuricaemia x
Lipase abnormal Lipase abnormal x
Exfoliative rash Exfoliative rash x
Posterior reversible encephalopathy syndrome Posterior reversible encephalopathy syndrome x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

REGORAFENIB

Side effects:52
Source:FDA Structured Product Label

regorafenib / regorafenib

Side effects:65
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label